HRP940577B1 - Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy - Google Patents

Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy

Info

Publication number
HRP940577B1
HRP940577B1 HR940577A HRP940577A HRP940577B1 HR P940577 B1 HRP940577 B1 HR P940577B1 HR 940577 A HR940577 A HR 940577A HR P940577 A HRP940577 A HR P940577A HR P940577 B1 HRP940577 B1 HR P940577B1
Authority
HR
Croatia
Prior art keywords
thia
hydrogen
diazabicyclo
octane
dioxo
Prior art date
Application number
HR940577A
Other languages
English (en)
Inventor
Lukić Irena
Original Assignee
Lukić Irena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lukić Irena filed Critical Lukić Irena
Priority to HR940577A priority Critical patent/HRP940577B1/xx
Priority to DE69501810T priority patent/DE69501810T2/de
Priority to AT95114673T priority patent/ATE164069T1/de
Priority to ES95114673T priority patent/ES2115303T3/es
Priority to EP95114673A priority patent/EP0705606B1/de
Priority to CZ952447A priority patent/CZ285621B6/cs
Priority to JP7241717A priority patent/JPH08310954A/ja
Priority to RU95116239A priority patent/RU2136284C1/ru
Priority to CA002158678A priority patent/CA2158678C/en
Priority to SI9500297A priority patent/SI9500297A/sl
Priority to HU9502770A priority patent/HU218287B/hu
Priority to CN95116888A priority patent/CN1127115A/zh
Priority to BG100020A priority patent/BG62237B1/bg
Priority to SK1170-95A priority patent/SK280815B6/sk
Publication of HRP940577A2 publication Critical patent/HRP940577A2/hr
Publication of HRP940577B1 publication Critical patent/HRP940577B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR940577A 1994-09-21 1994-09-21 Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy HRP940577B1 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
HR940577A HRP940577B1 (en) 1994-09-21 1994-09-21 Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy
DE69501810T DE69501810T2 (de) 1994-09-21 1995-09-18 Verwendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie
AT95114673T ATE164069T1 (de) 1994-09-21 1995-09-18 Verwendung von 5-thia-1,4-diazabicyclo (4.2.0> octane-3,8-dioxo verbindungen in der antitumor- therapie
ES95114673T ES2115303T3 (es) 1994-09-21 1995-09-18 Uso de compuestos de 5-tia-1,4-diazabiciclo(4.2.0)octan-3,8-dioxo en terapia antitumoral.
EP95114673A EP0705606B1 (de) 1994-09-21 1995-09-18 Verwendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie
CZ952447A CZ285621B6 (cs) 1994-09-21 1995-09-20 Použití 5-thia-1,4-diazabicyklo[4,2,0]oktan-3,8-dioxo-sloučenin v protinádorové terapii
JP7241717A JPH08310954A (ja) 1994-09-21 1995-09-20 製薬組成物
RU95116239A RU2136284C1 (ru) 1994-09-21 1995-09-20 Применение 5-тиа-1,4-диазабицикло[4.2.0]октан-3,8-диоксопроизводных в противоопухолевой терапии
CA002158678A CA2158678C (en) 1994-09-21 1995-09-20 Use of 5-thia-1, 4-diazabicyclo/4.2.0/octane-3,8-dioxo compounds in antitumor therapy
SI9500297A SI9500297A (en) 1994-09-21 1995-09-21 Use of 5-thia-1,4-diazabicyclo/4.2.0/octane-3,8-dioxo compounds in antitumor therapy
HU9502770A HU218287B (en) 1994-09-21 1995-09-21 Use of 5-thia-1,4-diazabicyclo[4.2.0]octane-3,8-dioxo compounds in antitumor therapy
CN95116888A CN1127115A (zh) 1994-09-21 1995-09-21 3,8-二氧代-5-硫代-1,4-二氮杂二环[4.2.0]辛烷化合物在抗肿瘤治疗中的应用
BG100020A BG62237B1 (bg) 1994-09-21 1995-09-21 Използване на5-тио-1,4-диазобицикло-[4,2,0]-октан-3,8-диоксосъединения приантитуморна терапия
SK1170-95A SK280815B6 (sk) 1994-09-21 1995-09-21 Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR940577A HRP940577B1 (en) 1994-09-21 1994-09-21 Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy

Publications (2)

Publication Number Publication Date
HRP940577A2 HRP940577A2 (en) 1997-04-30
HRP940577B1 true HRP940577B1 (en) 1998-12-31

Family

ID=10946157

Family Applications (1)

Application Number Title Priority Date Filing Date
HR940577A HRP940577B1 (en) 1994-09-21 1994-09-21 Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy

Country Status (14)

Country Link
EP (1) EP0705606B1 (de)
JP (1) JPH08310954A (de)
CN (1) CN1127115A (de)
AT (1) ATE164069T1 (de)
BG (1) BG62237B1 (de)
CA (1) CA2158678C (de)
CZ (1) CZ285621B6 (de)
DE (1) DE69501810T2 (de)
ES (1) ES2115303T3 (de)
HR (1) HRP940577B1 (de)
HU (1) HU218287B (de)
RU (1) RU2136284C1 (de)
SI (1) SI9500297A (de)
SK (1) SK280815B6 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598188A (en) * 1979-01-23 1980-07-25 Mitsui Toatsu Chem Inc Novel cephalosporin and its preparation
JPS57171994A (en) * 1981-04-15 1982-10-22 Asahi Chem Ind Co Ltd Novel compound
HRP921292A2 (en) 1992-11-17 1994-08-31 Pliva Pharm & Chem Works 5-thia-1,4-diazabicyclo (4.2.0.)octane -3,8-dioxo analogs of beta-lactams, the process for the preparation and use thereof

Also Published As

Publication number Publication date
SK280815B6 (sk) 2000-08-14
CZ244795A3 (en) 1996-04-17
ES2115303T3 (es) 1998-06-16
HU218287B (en) 2000-07-28
HUT74422A (en) 1996-12-30
DE69501810D1 (de) 1998-04-23
EP0705606A1 (de) 1996-04-10
CZ285621B6 (cs) 1999-10-13
HU9502770D0 (en) 1995-11-28
HRP940577A2 (en) 1997-04-30
ATE164069T1 (de) 1998-04-15
EP0705606B1 (de) 1998-03-18
SK117095A3 (en) 1996-09-04
CN1127115A (zh) 1996-07-24
CA2158678A1 (en) 1996-03-22
RU2136284C1 (ru) 1999-09-10
JPH08310954A (ja) 1996-11-26
BG100020A (bg) 1996-04-30
BG62237B1 (bg) 1999-06-30
CA2158678C (en) 2000-04-18
SI9500297A (en) 1996-04-30
DE69501810T2 (de) 1998-09-24

Similar Documents

Publication Publication Date Title
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
DE69817393D1 (de) Neue heterozyklische verbindungen
IL73258A0 (en) 7-aminoazolo(1,5-a)pyrimidines,their preparation and their use as fungicides
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
AU3744397A (en) Total synthesis of antitumor acylfulvenes
AU558433B2 (en) A fungicidal indanylbenzamide
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
MX9701949A (es) Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales.
ES8504731A1 (es) Un procedimiento para preparar antra 1,9-cd-7pirazol-6(2h)-onas
PL337188A1 (en) Derivatives of 17beta - allyloxy (thio) alkyl - androstane for modulation of meiosis
HU906230D0 (en) Process for the preparation of benzanilide derivatives and medical preparations containing them
HRP940577B1 (en) Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy
TW224973B (de)
DE3167347D1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof
GB2071098B (en) Dibenzocycloheptenylidenes and antiinflammatory compositions
ATE1506T1 (de) Derivate des dithiepinno (1,4)(2,3-c) pyrrols, ihre herstellung und sie enthaltende medikamente.
ES8402284A1 (es) Un procedimiento para la preparacion de indoles.
ATE225366T1 (de) 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
NZ216741A (en) 6-oxo-1,6-dihydropyridazines and pharmaceutical compositions
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
SE8105297L (sv) Imidazolderivat

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20000921

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20000922